These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11889674)

  • 1. Intravenous Allopurinol.
    Kaplow R
    Clin J Oncol Nurs; 2002; 6(2):110. PubMed ID: 11889674
    [No Abstract]   [Full Text] [Related]  

  • 2. [How to treat hyperuricemia and gout attacks in compensated kidney failure?].
    Gröbner W
    Dtsch Med Wochenschr; 2002 Mar; 127(11):576. PubMed ID: 11894180
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hyperuricemia and gout--treatment].
    Gröbner W; Walter-Sack I
    Dtsch Med Wochenschr; 2002 Feb; 127(5):210-3. PubMed ID: 11821994
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of asymptomatic hyperuricemia].
    Floege J
    Internist (Berl); 1997 Dec; 38(12):1233. PubMed ID: 9465329
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of gout.
    Cohen MG
    Intern Med J; 2011 Jan; 41(1a):70-1. PubMed ID: 21265967
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment failure gout: failure to treat?
    Perry ME; Madhok R
    Rheumatology (Oxford); 2010 Dec; 49(12):2233-4. PubMed ID: 20463191
    [No Abstract]   [Full Text] [Related]  

  • 7. Opportunities for improving medication use and monitoring in gout.
    Singh JA; Hodges JS; Asch SM
    Ann Rheum Dis; 2009 Aug; 68(8):1265-70. PubMed ID: 18701554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rasburicase in the prevention and treatment of tumour lysis syndrome.
    Mayne N; Keady S; Thacker M
    Intensive Crit Care Nurs; 2008 Feb; 24(1):59-62. PubMed ID: 17698360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gout management: let's get it right this time.
    Sundy JS
    Arthritis Rheum; 2008 Nov; 59(11):1535-7. PubMed ID: 18975368
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment with allopurinol decreases the number of acute gout attacks despite persistently elevated serum uric acid levels.
    Beutler AM; Rull M; Schlesinger N; Baker DG; Hoffman BI; Schumacher HR
    Clin Exp Rheumatol; 2001; 19(5):595. PubMed ID: 11579724
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hyperuricemia and gout: therapeutic indications].
    Pawlotsky Y
    Rev Prat; 1994 Jan; 44(2):206-9. PubMed ID: 8178077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout.
    Dalbeth N; Kumar S; Stamp L; Gow P
    J Rheumatol; 2006 Aug; 33(8):1646-50. PubMed ID: 16783857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of combined low dose of Allopurinol and benzbromarone compared to standard dose of Allopurinol in hyperuricemia.
    Akkasilpa S; Osiri M; Deesomchok U; Avihingsanon Y
    J Med Assoc Thai; 2004 Sep; 87(9):1087-91. PubMed ID: 15516011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary renal hypouricemia: a new role for allopurinol?
    Bhasin B; Stiburkova B; De Castro-Pretelt M; Beck N; Bodurtha JN; Atta MG
    Am J Med; 2014 Jan; 127(1):e3-4. PubMed ID: 24262806
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum urate during bouts of acute gouty arthritis.
    Schlesinger N; Baker DG; Schumacher HR
    J Rheumatol; 1997 Nov; 24(11):2265-6. PubMed ID: 9375898
    [No Abstract]   [Full Text] [Related]  

  • 16. [Rasburicase versus allopurinol in the treatment of hyperuricaemia in tumour lysis syndrome].
    Tatay VS; Castilla JD; Ponce JM; Hurtado JM; Cantero E; Abril ML
    An Pediatr (Barc); 2010 Feb; 72(2):103-10. PubMed ID: 20022572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of intravenous allopurinol in the management of acute tumor lysis syndrome.
    Feusner J; Farber MS
    Semin Oncol; 2001 Apr; 28(2 Suppl 5):13-8. PubMed ID: 11343273
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol.
    Reinders MK; van Roon EN; Jansen TL; Delsing J; Griep EN; Hoekstra M; van de Laar MA; Brouwers JR
    Ann Rheum Dis; 2009 Jan; 68(1):51-6. PubMed ID: 18250112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome.
    Davidson MB; Thakkar S; Hix JK; Bhandarkar ND; Wong A; Schreiber MJ
    Am J Med; 2004 Apr; 116(8):546-54. PubMed ID: 15063817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Febuxostat--treatment for hyperuricemia and gout?
    Moreland LW
    N Engl J Med; 2005 Dec; 353(23):2505-7. PubMed ID: 16339099
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.